APA (7th ed.) Citation

Butler, J., Hamo, C. E., Filippatos, G., Pocock, S. J., Bernstein, R. A., Brueckmann, M., . . . Anker, S. D. (2017). The potential role and rationale for treatment of heart failure with sodium–glucose co‐transporter 2 inhibitors. European journal of heart failure, 19(11), 1390-1400. https://doi.org/10.1002/ejhf.933

Chicago Style (17th ed.) Citation

Butler, Javed, et al. "The Potential Role and Rationale for Treatment of Heart Failure with Sodium–glucose Co‐transporter 2 Inhibitors." European Journal of Heart Failure 19, no. 11 (2017): 1390-1400. https://doi.org/10.1002/ejhf.933.

MLA (9th ed.) Citation

Butler, Javed, et al. "The Potential Role and Rationale for Treatment of Heart Failure with Sodium–glucose Co‐transporter 2 Inhibitors." European Journal of Heart Failure, vol. 19, no. 11, 2017, pp. 1390-1400, https://doi.org/10.1002/ejhf.933.